Amferia has invented a new antimicrobial hydrogel that targets, binds, and rapidly kills up to 99.99% of bacteria upon contact. The hydrogel consists of amphiphilic antibacterial polymers mimicking the immune system. Because the hydrogel binds those polymers in place, nothing is released into the wound, making the dressing safe for the body. 

‍

Appropriate for  low exuding wounds—such as post-surgical incisions and open wounds—this product can be used as a wound contacting hydrogel pad supported on the wound by a secondary dressing.

Meant exclusively for veterinary in-clinic use, in places such as surgical care units or in-patient care, all products are supplied sterile and will include instructions for use.  

Read more about the science behind Amferia's products >

‍

At Amferia, we had the privilege of interviewing Dr. Olivier Lepage, Chair of the Board of the European College of Veterinary Surgeons (ECVS), Professor of Equine Surgery, and Director of the Equine Health Center at the National Veterinary School of Lyon.

Veterinarians are looking forward to new innovations in wound healing

In this enlightening discussion, Dr. Lepage highlights the growing challenge of antibiotic resistance and the urgent need for innovative approaches to wound healing. He emphasizes the importance of developing antibacterial wound care products that offer broad-spectrum activity without interfering with the body’s natural tissue cells. Additionally, he encourages veterinarians to explore and adopt new innovations in animal wound care to enhance treatment outcomes.

This interview reflects Amferia’s ongoing commitment to collaborating with leading experts to create impactful and sustainable advancements in animal wound care.

Amferia technology is now available as BactiDefend Dressing within the Snögg Animal Care portfolio. BactiDefend Dressing is a sterile hydrogel formulation powered by Amferia technology, utilizing innovative peptides that mimic the immune system to bind to and disrupt bacteria without leaching harmful substances. The dressing also promotes wound healing by providing a moist environment. It is safe and biocompatible and intended for professional use only. Use on dry or low-exuding wounds. Snögg homepage >

• Countries where you can buy Snögg Wound Dressing with Amferia antibacterial hydrogel:‍
• Denmark,
• Finland,
• Germany,
• Norway,
• Portugal,
• Spain,
• Sweden,
• Iceland.

‍

• ‍“The ability to reduce systemic antibiotic usage is so important" ‍
• Dr Joanna Winestone, MRCVS, Vets4Pets, UK
• "Granulation tissue observed and visible change in bioburden"
• Dr, Peter Engelhardt, Anicura Haan, Germany
• "It was very easy and fits very well"
• Dr. Christian Nees, Anicura Weingarten, Germany
• "A very nasty wound with maggots cleared surprisingly fast"
• Veterinarian, Sweden
• "No infection observed despite a highly contaminated wound"
• Associate professor, Equine Surgery, Belgium

Product video - How to use Amferia non-adhesive hydrogel dressing

Amferia has collaborated with five leading veterinary clinics across Europe and obtained over 100 case reports on a variety of post-surgical wounds of cats and dogs.

‍

In each case, Amferia’s hydrogel dressing enabled safe healing of wounds with no complications. Furthermore, the product could be adapted easily to the complex contours of the animals' bodies and adjusted to the required sizes.

The surgeons who used the dressings have provided excellent feedback on the usability, safety and existing evidence of antimicrobial efficacy.

Clinical case reports involving Amferia hydrogel dressings have been performed on infected chronic wounds in collaboration with two clinics in Germany and the Netherlands.

Together with Amferia, the clinics have performed five case evaluations of the Amferia hydrogel dressing in hard-to-heal infected wounds of one dog and four cats, all colonized with multi-resistant pseudomonas aeuruginosa or MRSA bacteria.

All wounds were open wounds from either trauma or chronic complications, and the patients suffered from recurring wound complications over a period of two to three months. The attending wound specialist requested Amferia dressing for trials on the patients and noted a clear effect within 24 hours, noting bio-burden reduction and formation of new granulation tissue.

Amferia collaborated on an in-vivo infection model study with Chalmers University and the Department of Biomaterials at Sahlgrenska University. 

The study results, published in ACS Biomaterials Science, describe a wound model in mice heavily infected with bacteria. The results demonstrated 100 times reduction of bacterial load in the wounds treated with the amphiphilic antimicrobial hydrogel.  

This is especially impressive, given that the wound was deep and the bacterial load was extremely high. The results demonstrated the strong effect the hydrogel had on bacterial removal, from the wound in a statistically significant manner, without releasing any substances into the body. 

‍

‍

If you are interested in distributing our product, exploring a partnership, or are a veterinarian who would like to test the product and provide feedback, please reach out to us. We’re excited to collaborate and share the benefits of our innovative wound care solution with you!

‍Please contact our Sales Director Saba Atefyekta (PhD) for ordering information >

‍

Collaborate with us and receive samples for trials. Amferia is happy to provide samples of our current and upcoming products for early trials for post-surgical and other dry-to-low exuding wound applications.

Please contact our Product Manager Rojan Modaresi (DVM, PhD) with your interest for product trials >‍